89bio, Inc. (ETNB) Retained Earnings (Accumulated Deficit) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
89bio, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2018 to 2024.
  • 89bio, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$509 M, a 48% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$509 M -$165 M -48% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$457 M -$142 M -45.1% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$417 M -$127 M -43.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$382 M -$119 M -45% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$344 M -$105 M -44.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$315 M -$102 M -47.9% Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$291 M -$104 M -55.5% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$264 M -$105 M -66.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$239 M -$101 M -73.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$213 M -$90.1 M -73.2% Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$187 M -$76.4 M -69.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$159 M -$62.7 M -65.4% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 -$138 M -$53.7 M -63.9% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 -$123 M -$49.5 M -67.3% Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$111 M -$56.2 M -103% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 -$95.9 M Jun 30, 2020 10-Q 2020-08-13
Q1 2020 -$84.1 M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 -$73.6 M -$57.4 M -355% Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$54.3 M Sep 30, 2019 10-Q 2019-12-18
Q4 2018 -$16.2 M Dec 31, 2018 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.